3.4.3. Tyrosinase Inhibition Assay

JG Jakub Gębalski
MM Milena Małkowska
SW Sylwia Wnorowska
DG Dorota Gawenda-Kempczyńska
MS Maciej Strzemski
MW Magdalena Wójciak
AS Artur Słomka
JS Jan Styczyński
DZ Daniel Załuski
request Request a Protocol
ask Ask a question
Favorite

Tyrosinase inhibitor assays were conducted in 96-well plates using a modified method originally described by Wróbel-Biedrawa [51]. The process involves the conversion of L-tyrosinase to L-DOPA, then to DOPA-quinone, facilitated by the tyrosinase enzyme. This reaction results in the solution turning brown. In brief, 10 μL of the sample (concentrations of 10.0, 1.0, and 0.1 mg/mL in 10% DMSO) was combined with 150 μL of a phosphoric buffer containing mushroom tyrosinase (pH = 6.88, 100 U/mL). This mixture was then incubated for 10 min at room temperature. A control (AC) was also prepared that did not contain any inhibitor. Following incubation, L-tyrosine (0.3 mg/mL) was added to each well, and the absorbance was measured at 492 nm (using a kinetic model every 5 min). Two time points (t1 and t2) were selected within the linear range of the graph. All samples were tested in triplicate. The inhibition of tyrosinase was calculated using a specific equation, with kojic acid used as a standard.

AS—the difference in absorbance between times t2 and t1 for the sample;

AC—the difference in absorbance between times t2 and t1 for the positive control.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A